Assessing the impact of COVID-19 on the health of geriatric patients: The European GeroCovid Observational Study
- PMID: 33573885
- PMCID: PMC7847394
- DOI: 10.1016/j.ejim.2021.01.017
Assessing the impact of COVID-19 on the health of geriatric patients: The European GeroCovid Observational Study
Abstract
Background: Despite the growing evidence on COVID-19, there are still many gaps in the understanding of this disease, especially in individuals in advanced age. We describe the study protocol of GeroCovid Observational, a multi-purpose, multi-setting and multicenter initiative that aims at investigating: risk factors, clinical presentation and outcomes of individuals affected by COVID-19 in acute and residential care settings; best strategies to prevent infection in long-term care facilities; and, impact of the pandemic on neuropsychologic, functional and physical health, and on medical management in outpatients and home care patients at risk of COVID-19, with a special focus on individuals with dementia.
Methods: GeroCovid involves individuals aged ≥60 years, at risk of or affected by COVID-19, prospectively or retrospectively observed since March 1st, 2020. Data are collected in multiple investigational sites across Italy, Spain and Norway, and recorded in a de-identified clinical e-Registry. A common framework was adapted to different care settings: acute wards, long-term care facilities, geriatric outpatient and home care, and outpatient memory clinics.
Results: At September 16th, 2020, 66 investigational sites obtained their Ethical Committee approval and 1618 cases (mean age 80.6 [SD=9.0] years; 45% men) have been recorded in the e-Registry. The average inclusion rate since the study start on April 25th, 2020, is 11.2 patients/day. New cases enrollment will ended on December 31st , 2020, and the clinical follow-up will end on June 30th, 2021.
Conclusion: GeroCovid will explore relevant aspects of COVID-19 in adults aged ≥60 years with high-quality and comprehensive data, which will help to optimize COVID-19 prevention and management, with practical implications for ongoing and possible future pandemics.
Trial registration: NCT04379440 (clinicaltrial.gov).
Keywords: COVID-19; Health Services for the Aged; Inpatients; Nursing Homes; Observational Study; Outpatients.
Copyright © 2021. Published by Elsevier B.V.
Conflict of interest statement
None.
Figures
Comment in
-
The peculiarities of COVID-19 in older people: Considerations after two years.Eur J Intern Med. 2023 Nov;117:45-49. doi: 10.1016/j.ejim.2023.09.021. Epub 2023 Sep 29. Eur J Intern Med. 2023. PMID: 37778903 No abstract available.
Similar articles
-
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).Trials. 2020 Oct 13;21(1):846. doi: 10.1186/s13063-020-04619-1. Trials. 2020. PMID: 33050924 Free PMC article. Clinical Trial.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5. Trials. 2021. PMID: 33430924 Free PMC article.
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.Trials. 2021 May 17;22(1):343. doi: 10.1186/s13063-021-05181-0. Trials. 2021. PMID: 34001215 Free PMC article.
-
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0. Trials. 2021. PMID: 33810796 Free PMC article.
Cited by
-
Determinants of Cause-Specific Mortality and Loss of Independence in Older Patients following Hospitalization for COVID-19: The GeroCovid Outcomes Study.J Clin Med. 2022 Sep 22;11(19):5578. doi: 10.3390/jcm11195578. J Clin Med. 2022. PMID: 36233447 Free PMC article.
-
"This path I must walk alone". Challenges experienced by older patients while recovering from severe COVID-19 - a qualitative study.BMC Geriatr. 2022 Mar 28;22(1):253. doi: 10.1186/s12877-022-02959-y. BMC Geriatr. 2022. PMID: 35346076 Free PMC article.
-
Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study.Vaccine. 2022 Apr 1;40(15):2324-2330. doi: 10.1016/j.vaccine.2022.02.064. Epub 2022 Feb 22. Vaccine. 2022. PMID: 35248424 Free PMC article.
-
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study.Eur Geriatr Med. 2023 Jun;14(3):465-476. doi: 10.1007/s41999-023-00790-1. Epub 2023 May 19. Eur Geriatr Med. 2023. PMID: 37204681 Free PMC article.
-
High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures.Rev Esp Quimioter. 2022 Jun;35(3):288-292. doi: 10.37201/req/008.2022. Epub 2022 Apr 11. Rev Esp Quimioter. 2022. PMID: 35397483 Free PMC article.
References
-
- Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, Holstein R. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 — COVID-net, 14 states. Morb Mortal Wkly Rep. 2020;69:458–464. doi: 10.15585/MMWR.MM6915E3. 2020. - DOI - PMC - PubMed
-
- Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous